Kim Giffoni, EVP Foreign Sales/Inv. Rel at Targeted Medical Pharma, Inc. (TRGM), bought 1,000 shares at $0.90 ($900) on 2013-12-12, disclosed to the SEC on 2013-12-16.
Open-market purchase of $900 TRGM by EVP Foreign Sales/Inv. Rel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| TRGM | BUY | 2013-12-04 | $5K | — | Filing → |